Order Article Reprints

Sengupta A, Azharuddin M, Cardona ME, Devito C, von Castelmur E, Wehlin A, Pietras Z, Sunnerhagen M, Selegård R, Aili D, et al. Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein. Vaccines. 2022; 10(4):504. https://doi.org/10.3390/vaccines10040504

Sengupta, Anirban, Mohammad Azharuddin, Maria E. Cardona, Claudia Devito, Eleanore von Castelmur, Anna Wehlin, Zuzanna Pietras, Maria Sunnerhagen, Robert Selegård, Daniel Aili, and et al. 2022. "Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein" Vaccines 10, no. 4: 504. https://doi.org/10.3390/vaccines10040504

Sengupta, A., Azharuddin, M., Cardona, M. E., Devito, C., von Castelmur, E., Wehlin, A., Pietras, Z., Sunnerhagen, M., Selegård, R., Aili, D., Alamer, A., Hinkula, J., & Al-Otaibi, N. (2022). Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein. Vaccines, 10(4), 504. https://doi.org/10.3390/vaccines10040504